INTRODUCTION
Treatment planning for boron neutron capture therapy (BNCT) requires the calculation of the total dose at all points of interest in the irradiated patient resulting from fast-and thermal-neutron interactions as well as from incident photons. Thermal neutrons have an average energy of 25 meV and interact with the 10B nucleus to produce high-LET radiation, on which principle BNCT is based. With the aim of treating deep-seated tumors, an epithermal neutron beam has been designed and installed at the HB11 facility in the High Flux Reactor at Petten (1) . Thermalization of the incident epithermal neutrons in hydrogenous tissue typically results in a maximal thermal-neutron fluence at a depth of approximately 2.5 cm. A major goal in BNCT treatment planning is to obtain a homogeneous thermalneutron fluence distribution over the target volume, with maximal sparing of surrounding normal tissue. Due to the bimodal nature of this type of irradiation not only is the thermal-neutron fluence distribution important but also the 10B concentration in the tumor and various tissues is one of the critical parameters. For the purpose of the present study, we have used a simplified model, in which a homogeneous boron distribution in the target volume and in the normal tissues was assumed.
Monte Carlo simulation is the most common method for solving the Boltzmann equation for particle transport. Its results are very reliable, but Monte Carlo calculations are usually time consuming. Other and more rapid methods are the discrete-ordinates deterministic technique (2) and a semi-empirical approximation based on the relatively simple photon transport problem. In the discrete-ordinates technique a set of discrete angular directions is predefined at each space-point in a finite-difference mesh folded over the spatial geometry involved. The neutron (or photon) fluence at each point is then calculated iteratively for each step in a multigroup energy structure defined by the source by an approximation by a weighted sum of the results of the Boltzmann equation over the discrete directions. The partitioning of the geometry into a mesh is the main disadvantage of this method, as the state-of-the art code [TORT (3) ] is limited to regular rectangular or cylindrical geometries. Material inhomogeneities, however, can be explicitly included in this method. In the semi-empirical method no attempt is made to solve the Boltzmann equation exactly (4) . Instead, total dose, thermal-neutron fluence and photon dose curves along the central axis of the beam and axial profiles are measured in reference phantoms and fed into a conventional externalbeam treatment planning program. The neutron transport problem can then be replaced empirically by photon-beam or electron pencil-beam algorithms with an increase of the scatter component. Disadvantages of this method are that the influence of the phantom or beam geometry as well as influences from material inhomogeneities on the dose distribution are not taken into account adequately unless they have been measured explicitly.
Monte Carlo techniques rely on pseudo-random numbers with probabilities defined by the cross section of the medium through which the particle passes, to decide on the path this particle follows until it stops by a capture reaction. During various interactions secondary particles may be emitted, which are then also followed along their path through the medium. For a large number of events the information scored on neutron and photon fluence and energy distribution will minimize any statistical fluctuation allowed in the physical phase space (allowed values for momentum and position of the particles) sampled by the Monte Carlo calculation. For the current study the multipurpose code MCNP (5) was used for benchmark treatment planning calculations. A disadvantage of this program is that it accepts only regularly defined geometries, like spheres, cubes, cones and ellipsoids, and cannot cope with irregular shapes such as patient contours obtained, for instance, from CT and MRI scans, target volumes and organs at risk.
Most current treatment planning programs for BNCT with epithermal neutrons are based on the Monte Carlo method. Only the work of Nigg et al. (2) demonstrated that the 3D deterministic radiation transport code TORT, applied at the Brookhaven Medical Research Reactor BNCT facility, can produce very detailed spatial dose distributions in an approximate patient geometry. The computer time, however, was even longer than for the Monte Carlo method. Their results confirm the findings from calculations based on MCNP using ideal monoenergetic neutron beams in various types of phantoms by Yanch et al. (8) , Yanch and Harling (9) and Gupta et al. (11) . An important finding was that reduction of the geometric epithermal neutron-beam portal area not only proportionally reduces the treatment field dimension as in photon therapy, but decreases the absolute value of the maximum dose considerably, quite contrary to photon therapy, where only relatively small reductions of the maximum dose are observed with reduced field size. (12, 13) and the SBNCT Plan (14) treatment planning systems, CT scans are partitioned into squares with uniform composition. These squares are used to construct a voxel mesh structure to define the whole volume of interest that can then be input for MCNP. The NCT Plan is capable of calculating spatial dose distributions for two parallel opposed 30-cm-diameter epithermal neutron beams, thereby allowing one to specify the dose in special regions, like the target volume or brain stem, within the overall voxel structure. The INEL BNCT treatment planning program (15) uses a B-spline reconstruction method BNCT edit to outline any region of interest in a medical image (skin, skull, brain, planning target volume, eyes, optic nerve, etc.). These surfaces can then be entered into rtt MC, a Monte Carlo code specially designed for BNCT, which produces isodose curves in each volume with its boundary defined by the B-spline surfaces.
In previous studies some preliminary results of the thermal-and fast-neutron fluence spatial distributions in phantoms were presented both with MCNP calculations and experimentally for an epithermal neutron beam from the Low Flux Reactor in Petten (23) . The aim of the present study was to investigate the therapeutic possibilities of the epithermal neutron therapy beam from the High Flux Reactor in Petten in more detail. The relative spatial dose distributions have been evaluated independently of RBE assignment. The influence of field size and multiple field irradiations has been studied on the dose homogeneity in a planning target volume, as well as on sparing healthy tissue. Isodose curves and dose-volume histograms have been calculated to quantify the merits of a specific irradiation technique.
METHODS AND MATERIALS
To obtain an epithermal neutron beam (with energies varying between about 1 eV and 10 keV) a large filter assembly consisting of aluminum, sulfur, titanium, cadmium and liquid argon has been installed in the HB11 beam of the High Flux Reactor in Petten (6, 16) . A circular beam of 8 cm diameter was used initially, which proved to be suitable for the studies of tissue tolerance in dogs (7) . To obtain homogeneous thermal-neutron fluences over deep-seated tumors, the use of epithermal neutron field widths comparable to the size of a human head needs to be investigated. For a wide field the epithermal neutrons enter the head over a large area, giving more neutrons the chance to thermalize and reach the target region (2, 8, 11) .
For human irradiations new collimators have been designed, made of 5-cm-thick lead layers and borated polyethylene sheets lined with lithium-polyethylene to reduce the dose from incident capture y rays on the patient. The actual circular beam sizes of 8, 12 and 15 cm diameter have been investigated in this study. Beam collimators in clinical photon radiotherapy generally have a rectangular shape. In neutron capture therapy, however, the beam shape is commonly not considered to be relevant due to the selectivity of the therapy and to the high neutron scattering. To show the influence of the neutrons coming from the outer 
Phantoms
The influence of the phantom geometry on the thermal-neutron distribution decreases with the increase in beam size according to Yanch et al. (8) . To investigate the influence of beam size and beam shape on the dose distribution, it is therefore important to perform these investigations in a phantom with a minimal distortion of the thermal-neutron distribution inside. Two phantoms were modeled, a cube and an ellipsoid "human head like" phantom as advocated by Deutsch and Murray (19) and shown in Fig. 1 . A 30-cm cube made of 6-mm-thick PMMA walls filled with demineralized water to 27 cm height was used for our study. With a remotely controlled positioning device it is possible to scan through the whole volume of this phantom. Several detector systems, including paired ionization chambers, a semiconductor thermal-neutron detector, activation foils and TLDs, are in use to measure the beam characteristics within this phantom (10) . A comparison of these measurements and Monte Carlo calculations is in progress.
Monte Carlo Model
The neutron dose and the thermal-neutron fluence spatial distributions within the two types of phantom were calculated with MCNP models designed for the HB11 therapy facility at the High Flux Reactor in Petten. The dose and fluence were specified at each point of a 1-cm3 regular mesh superimposed over the phantom geometry. The total dose coming from boron, hydrogen and nitrogen capture reactions and proton recoils was then derived from the thermal-neutron fluences and the neutron doses. For the design phase of the filter assembly, a very detailed MCNP model of the HFR core and HB11 beam and filter geometry was made (16) . Calculations with this model were performed to establish the neutron energy spectrum and neutron fluence across the surface in front of (at the reactor side) the collimator. This spectrum was used as a neutron source in consecutive calculations, with the possibility of defining different types of collimators. Calculations following this two-step model have been tested extensively in both free-beam (17) and phantom experiments (18).
With a simple transformation command in MCNP it is possible to rotate and translate the phantom to any orientation, e.g. for multiportal irradiations. In both phantoms the internal volumes were folded with a 1-cm3 element mesh structure to calculate the neutron fluence and dose at each point within the phantom filling, i.e. water and brain, with the composition given in Table I . Dose distributions have not been determined within the PMMA walls and the skull, since, for the worst case of single-field irradiations of dogs, the radiation damage to the dog's scalp proved to be less than in the brain tissue (7) . In the ellipsoid head phantom a planning target volume, typical for primary brain tumor treatment, was drawn by the radiation oncologist. This volume involves the actual tumor site surrounded by a margin of approximately 1 cm in which peripheral tumor cells exist, at 3 cm depth in the head phantom. The planning target has a volume of 105 cm3 spreading out from 2.8 cm depth to the brain midline at 6.8 cm depth. Combinations of various neutron fields were tried to obtain the most homogeneous dose distribution over the target volume. The assumption was made that in the skull the 10B concentration was 10 pg/g, thereby accounting for the higher amount of blood in the scalp, the brain 5 pg/g 10B and in the target volume 30pLg/g 10B. Similar concentrations were recommended by the 1989 MIT Workshop on Neutron Beam Design (21) . This uniform tumor-to-brain ratio of 6:1 may be a little too optimistic over the whole target volume as the tumor itself will be debulked prior to the irradiation. The resulting cavity will be filled with necrotic tissue and CNS fluid with hardly any boron if the blood-brain barrier remains intact despite the surgery. The depression of the boron concentration in the center of the target area will have no influence on the thermal-neutron fluence distribution. The hydrogen concentration in the target area is assumed to remain unaltered. Hence comparisons have been made with the situation in which the boron is spread homogeneously over the whole brain volume with a concentration of 10 tg/g 10B, as well as with the intermediate situa- tion of 20 pg/g 10B in the target volume and 10 plg/g elsewhere. The volumes of the cubes intersected by either the brain or the planning target boundaries have been determined with stochastic sampling. All simulations were run on a SUN-Sparc2 workstation with the MCNP code version 3b (5, 16) . For each run particles were followed with the energy spectrum coming from the source plane across the entrance of the conical collimator with an intensity distribution proportional to its radial distance and isotropically within the forward 100 solid angle, in the 5' angled beam direction, to score the neutron dose rate and the neutron fluence rates in each point of the mesh. Both phantoms were always placed with their front surface perpendicular to the beam.
Dose Calculation
The neutron dose rate is calculated by an integration of the neutron fluence rate spectrum with the neutron kerma factors from ICRU report 26 (22) integrated over the energy. Instead of calculating the total dose rate directly in MCNP, it is derived from a summation of the (fast) neutron dose rate and the thermal-neutron fluence rate multiplied with a fluence-to-kerma conversion factor. The kerma factors for various boron concentrations are listed in Table II and consist of the macroscopic cross section and energy released from the thermal-neutron capture reactions: 10B(n,c0)7Li, 14N(n,p)14C and H(n,y). It is assumed that all clinically relevant dose distributions are covered by tumor-to-brain boron concentration ratios of 6:1, 2:1 and 1:1 (24, 25) . For the charged-particle reaction products the amount of energy released per unit thermal-neutron fluence was converted directly to a dose rate with the conversion factor 1 MeV/g = 1.6022 x 10-(? Gy. In the case of capture y rays a kerma factor of 0.816 x 10-11 Gy/photon/cm2 (22) (Compton effect) for 2 MeV photons was used. The long-range MeV capture y rays will pass through a voxel, losing hardly any of their energy. In the whole brain volume, however, y rays arriving from neighboring voxels will compensate for the y rays leaving the considered voxel. It was further assumed that electron equilibrium exists and that the whole photon energy is released within the 1-cm3 cube. This assumption was not considered to be valid in the skull. The actual dose in the phantoms needs a further modification by the addition of the y--ray component already present in the beam. Because it is impossible in MCNP to define a coupled neutron and photon source, this dose component must be calculated in a separate photon source calculation with MCNP. It is modeled accurately by a uniform dose rate of 1 Gy/h. All dose calculations and the presentation graphics were performed on a VAX-6300 computer in routines based on Fortran and Uniras software.
RESULTS

Cubic Phantom
The thermal-neutron fluence distributions calculated for the circular 8-, 12-and 15-cm-diameter beam, the rectangular 8 x 15-cm beam and the doughnut-shaped beam as a function of depth are shown in Fig. 2a , and the thermalneutron fluence profiles transverse to the incoming field are shown in Fig. 2b . As put forward by Yanch et al. (8) , the wider beam causes a somewhat deeper penetration of the thermal-neutron fluence into the phantom, which is confirmed by the curves presented in Fig. 2a for several beam diameters. The flattest distribution with the deepest penetration is obtained with the doughnut-shaped collimator. For BNCT, however, it would be dangerous to rely on the thermal-neutron distribution only, and therefore all dose contributions must be considered, regardless of the boron distribution. It should be noted that the neutron transport in this phantom was calculated for water, without boron or nitrogen. The dose distribution calculated for an overall 10 ppm 10B concentration within the cubic phantom is depicted in Fig. 3 for the three circular collimators.
Due to the high scattering cross section of hydrogen the beam profiles in the phantoms all show a semicircular wavefront shape, influenced only by the beam diameter. The influence of the collimator shape on the dose distribution 10B 10.33
Notes. The weight concentrations of the active elements correspond to the tissue compositions given in Table I . With the macroscopic cross sections I and the energy released Er the kerma factors were calculated according to ref. (22) . comparable to the width for a 15-cm circular beam, whereas this width in the coronal plane is 6 cm, which is comparable to the 12-cm-diameter beam. The effect of the neutrons originating from the outer regions in the 15-cm-diameter collimator on the isodose curves is shown in Fig. 5 . A comparison with Fig. 3c reveals an increase in the 80% isodose region with a slightly smaller maximum dose region for this beam compared with the circular beam. The thermal-neutron fluence distribution is influenced only slightly by the block. The small asymmetry, already visible in the other isodose curves as well as in Fig. 2 , shows up more clearly in this figure, which might be explained by the 5' angle between the HB11 beam direction and the reactor core.
Ellipsoidal Phantom
Single-field irradiation for BNCT will result in a steep fall-off of the dose in any part of a deep-lying planning target volume. For an 8-cm-diameter circular field the variation in the dose over the planning target volume amounts to 65% (normalized to the maximum in the target volume) for concentrations below 30 pg/g almost independent of the 10B level, as shown in Table III All isodose curves in the ellipsoid model are given relative to the dose at the reference point, which is located at the center of the planning target volume, according to recommendations of the ICRU (26) . An increase of the dose homogeneity is seen with the increase in beam diameter as shown in Fig. 6 . Despite the fact that the beam axis is directed toward the center of the planning target volume, all isodose curves show a shift toward the center of the ellipsoid. A similar shift was seen in all other orientations of the ellipsoid in the beam.
The curved surface of the ellipsoid produces a deeper penetration of the thermal-neutron distribution.
At the center of the planning target volume the relative statistical uncertainty of the calculated dose rate is approximately 20% [e.g. for the 8-cm beam the neutron dose rate is 0.36 ? 0.06 (1 SD) Gy/h, and at dose maximum the uncertainty is 0.5%], and 2% in the thermal-neutron fluence rate. To stay within these boundaries, for the 8-cm beam 3 x 106 neutrons were followed whereas for the 15-cm-diameter beam 2 x 106 were sufficient, due to its higher penetration. The cubic phantom took 21 h of CPU time to calculate, Notes. The reference point is taken at the center of the planning target volume. All values are given relative to the dose in this reference point.
whereas the calculation for the elliptical phantom took 24 h of CPU time.
Multiportal Irradiations
With single-field irradiations in BNCT it is difficult to produce a satisfactory therapeutic dose to any nonsuperficial tumor. In the ellipsoid phantom, for instance, the minimum dose in the planning target volume is just 1.7 times the maximum dose in the healthy tissue for the most favorable situation of a 15-cm beam and 10B concentrations of 30 ppm in the planning target volume and 5 ppm in the healthy brain. A more pessimistic boron distribution of 20 ppm 10B in the planning target volume and 10 ppm elsewhere would produce an unacceptable ratio of 0.8 between the minimum dose at the planning target volume and the maximum dose in the healthy tissue. By introducing an RBE and compound factor correction (24) to the contributions of the dose from other than y rays, an even worse situation may occur because the fast-neutron RBE would increase the dose to healthy tissue, while the compound factor decreases the '1B(n,a) dose. The tumor-dose homogeneity as well as the ratio of the dose to the planning target volume and the healthy tissue during a single-field irradiation need to be increased. Therefore, bilateral-field irradiations have been calculated and are shown in Fig. 7 . Clearly the larger fields produce a more homogeneous dose distribution in the planning target volume. For the single-field 15-cm-diameter beam the dose variation is about 30% in the planning target volume. By using parallel opposed equally weighted beams this dose variation can be lowered to 10%. The maximum dose to the healthy tissue is lowered by 6 to 13%, depending on the boron concentration. Maximum dose homogeneity is obtained with four fields, as shown in Fig. 8 . For a fourfield irradiation with 15-cm-diameter fields the variation of the dose in the planning target volume is within ?10%. The benefit over a bilateral field irradiation is minimal for this large diameter field, as the variation of the dose in the planning target volume and the dose in the healthy tissue are comparable in both irradiations. A considerable part of the primary beam directed toward the center of the planning target volume on the shorter ellipsoid sides, with the width of 13.6 cm, will largely miss the phantom. Hence it is not to be expected that the dose in the planning target volume will be influenced noticeably by the field size on these sides. For two 8-cm fields on the shorter sides combined with two fields of 12 and 15 cm the minimum dose in the planning target volume is 87 and 90%, respectively, the maximum dose in the planning target volume is 108% for both, and the maximum healthy tissue dose does not change from the 29% given in Table III . The effect of these tangential fields, i.e. with beam sizes larger than the phantom boundary surface, on the dose distribution has not been investigated fully.
From the isodose distributions in the cubical phantom the rectangular field shape proved to be in producing a flatter beam profile at depth in tissue. In the ellipsoid phantom single-and multiple-field irradiations with the 8 X 15-cm collimator have been calculated and are presented in Fig. 9 . The dose homogeneity obtained in the planning target volume of +35, ?15 and ?13% for the single-, two-and fourfield irradiation, respectively, is comparable to the results for the larger circular collimators.
For all irradiations of the ellipsoid phantom, dose-volume histograms have been made for the total healthy brain and the planning target volume. As shown in Fig. 10 , the larger field produces dose-volume histograms with steeper slopes, both in the healthy brain and in the planning target volume. These observations illustrate in another way the earlier finding that a large beam diameter and multiple fields are necessary to obtain maximum dose homogeneity in the planning target volume. The concave shape of the dose-volume histogram of the healthy brain is caused by the inhomogeneous fast-neutron dose delivery, which is seen most strongly in the single small-diameter field. By using multiple fields, or larger beam widths, the neutron dose is leveled out over a larger volume, which results in a steeper slope. In the planning target volume the effect of the neutron dose is minimal, and the difference in the slopes of the curves presented in Fig. 10 is caused mainly by the deeper thermal-neutron penetration by the larger fields. Adding more fields clearly helps to produce more homogeneous fields in the planning target volume. The relative difference between the planning target volume dose-volume histograms caused by the 12-and the 15-cm-diameter beam diminishes and actually falls within the statistical fluctuations for the four-field irradiation. The dose-volume histogram for the healthy tissue is different, however, for the various beam sizes, thus giving the possibility of sparing radiation-sensitive organs. For a better understanding of the efficacy of different irradiation schemes the dose-volume histograms for specific organs, like the eyes, the optic chiasm and the brain stem, have to be determined as well.
DISCUSSION AND CONCLUSIONS
The dose distributions, calculated with the Monte Carlo program MCNP, in a cuboid water-filled phantom for the BNCT beam at the High Flux Reactor at Petten are quite different from dose distributions produced by photon therapy beams in such a phantom. The thermal-neutron distribution results agree with the calculations and measurements by Gupta et al. (11) for an accelerator-based epithermal neutron beam. Increase in beam size produces a deeper penetration of the dose in the phantom. Thermal-neutron distributions in the phantom for circular beam collimators, as manufactured for the Petten therapy beam, do not differ too much from rectangular or doughnut-shaped collimators with equivalent beam areas. Collimator shape, however, is very dominant in the neutron dose. Special collimator designs may be needed to reduce the fast-neutron (skin) dose to the patient.
Monte Carlo calculations for the Petten BNCT facility show that at least two lateral opposed neutron beams irradiating a clinically relevant phantom are needed to improve the dose homogeneity in the planning target volume as well as to lower the dose to the healthy tissue. As long as the boron spatial distribution within the target volume is unknown, this consideration is based on the assumption of a homogeneous boron distribution. Therefore, the treatment planning for deep-lying target volumes can be based on the thermal-neutron fluence distribution. Whether the relatively smaller increase in dose homogeneity with a four-field irradiation really is relevant in the clinic remains to be seen, especially since the two extra fields imply two different patient positionings. The curved boundaries of the ellipsoid phantom produce a more uniform thermal-neutron fluence distribution at depth compared with the cuboid phantom, which was also observed by Yanch et al. (8) for monoenergetic epithermal neutron beams. This effect shows the need for a treatment planning program capable of calculating the neutron transport problem and the BNCT dose within realistic patient contours.
For treatment planning calculations the most important feature is to design an irradiation scheme which minimizes the dose delivered to the healthy tissue. To obtain an objective criterion for any possible combination of incoming fields, the normal tissue complication probability can be determined using, for instance, the dose-volume histogram reduction method of Kutcher et al. (27) . Especially the relatively large fast-neutron component of the healthy tissue dose needs to be determined accurately, and the outcome of these calculations will be compared with extensive clinical dosimetry measurements, to be performed in the reference cuboid phantom. These experiments will help a BNCT treatment planning procedure capable of giving the patient's dose quickly and accurately for multiple fields of various sizes and forms. For speed and patient treatment planning MCNP is not suitable; accurate comparisons with experiments and benchmark calculations, however, largely benefit from the use of MCNP.
